A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/445 (2006.01) A61K 31/451 (2006.01) A61K 31/453 (2006.01)
Patent
CA 2185512
Disclosed is a medicine for treating tinnitus in a mammal which comprises a therapeutically effective amount of a compound of the formula Image (I) (wherein: (a) R2 and R5 are taken separately and R1, R2, R3 and R4 are each independently hydrogen, C1-C6 alkyl, halo, CF3, OH or -OR7 and R5 is methyl or ethyl; or (b) R2 and R5 are taken together and are Image , forming a chroman- 4-ol ring, and R1, R3 and R4 are each independently hydrogen, C1-C6 alkyl, halo, CF3, OH or -OR7; R6 is Image , Image or Image ; R7 is methyl, ethyl, isopropyl or n-propyl; R8 is phenyl optionally substituted with up to three substituents independently selected from the group consisting of (C1-C6) alkyl, halo or CF3; X is O, S and (CH2)n; and n is 0, 1, 2 or 3) or a pharmaceutically acceptable salt thereof, and (2) a pharmaceutically acceptable carrier.
Sands Steven B.
Pfizer Inc.
Smart & Biggar
LandOfFree
Treatment of tinnitus using neuroprotective agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of tinnitus using neuroprotective agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of tinnitus using neuroprotective agents will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1448398